XenoPort: Horizant likely available in early June – Businessweek

by admin on May 17, 2013

XenoPort: Horizant likely available in early June
Businessweek
(AP) — Drug developer XenoPort said Friday that its treatment for restless leg syndrome, Horizant, will likely be available to U.S. patients in early June. Last month XenoPort Inc. said that there was a shortage of Horizant, with patients telling them

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: